GH-Inhibitory Activity of Novel Somatostatin Agonists: Potential Applications in Acromegaly

E-ISSN： 1875-6107|5|3|277-291

ISSN： 1568-0134

Source： Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol.5, Iss.3, 2005-06, pp. : 277-291

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modular Design of a Novel Chimeric Protein with Combined Thrombin Inhibitory Activity and Plasminogen-Activating Potential

By Wirsching F. Luge C. Schwienhorst A.

Molecular Genetics and Metabolism, Vol. 75, Iss. 3, 2002-03 ,pp. : 250-259

Academic Press

Access to resources Recommend Favorite

Cancer immunotherapeutic potential of novel small molecule TLR7 and TLR8 agonists

By Hamm Svetlana Rath Sandra Michel Susanne Baumgartner Roland

Journal of Immunotoxicology, Vol. 6, Iss. 4, 2009-12 ,pp. : 257-265

Informa Healthcare

Access to resources Recommend Favorite

Multiple potential regulatory sites of TLR4 activation induced by LPS as revealed by novel inhibitory human TLR4 mAbs

By Tsukamoto Hiroki Fukudome Kenji Takao Shoko Tsuneyoshi Naoko Ihara Hideyuki Ikeda Yoshitaka Kimoto Masao

International Immunology, Vol. 24, Iss. 8, 2012-08 ,pp. : 495-506

Oxford University Press

Access to resources Recommend Favorite

Structural requirements and applications of inhibitory oligodeoxyribonucleotides

By Ashman Robert

Immunologic Research, Vol. 39, Iss. 1-3, 2007-11 ,pp. : 4-14

Humana Press, Inc

Access to resources Recommend Favorite

Sequence requirements for oligodeoxyribonucleotide inhibitory activity

By Ashman Robert F. Goeken J. Adam Drahos Jennifer Lenert Petar

International Immunology, Vol. 17, Iss. 4, 2005-04 ,pp. : 411-420

Oxford University Press

Access to resources Recommend Favorite